Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Is PAX2 a Reliable Marker in Differentiating Diffuse Malignant Mesotheliomas of Peritoneum From Serous Carcinomas of Müllerian Origin?

Is PAX2 a Reliable Marker in Differentiating Diffuse Malignant Mesotheliomas of Peritoneum From... Downloaded from http://journals.lww.com/appliedimmunohist by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/10/2020 RESEARCH ARTICLE Is PAX2 a Reliable Marker in Differentiating Diffuse Malignant Mesotheliomas of Peritoneum From Serous Carcinomas of Mu¨llerian Origin? Faye F. Gao, MD, PhD, Alyssa M. Krasinskas, MD, and Mamatha Chivukula, MD, FCAP, FASCP peritoneal carcinomatosis or extraovarian carcinoma. In Abstract: Diffuse peritoneal malignant mesotheliomas (DPMM) contrast, serous carcinomas (SC) are an aggressive type of are often disseminated in the peritoneal cavity as multiple cancers that arise from various organs of mullerian lineage nodules including localized masses in the ovaries that are including ovaries, endometrium, fallopian tubes, perito- clinically and histologically similar to serous adenocarcinomas neum, and cervix. Primary peritoneal serous carcinoma of mullerian origin. It is imperative to differentiate these tumors (PPSC) and ovarian serous carcinoma (OSC) are 2 given their diverse responses to chemotherapy and/or radio- histologically similar SC of mullerian origin that have the therapy. PAX2 gene was recently demonstrated in benign propensity to spread to the serosal surface. DPMM may epithelial cells of the female genital tract and in serous also histologically show a carcinomatous growth pattern carcinomas (SC) of mu¨ llerian origin. The aim of our study and is easily confused with PPSC. Although the criteria http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Applied Immunohistochemistry & Molecular Morphology Wolters Kluwer Health

Is PAX2 a Reliable Marker in Differentiating Diffuse Malignant Mesotheliomas of Peritoneum From Serous Carcinomas of Müllerian Origin?

Loading next page...
 
/lp/wolters-kluwer-health/is-pax2-a-reliable-marker-in-differentiating-diffuse-malignant-lhCoOXfjyP

References (29)

Publisher
Wolters Kluwer Health
ISSN
1541-2016
DOI
10.1097/PAI.0b013e3182366531
Publisher site
See Article on Publisher Site

Abstract

Downloaded from http://journals.lww.com/appliedimmunohist by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/10/2020 RESEARCH ARTICLE Is PAX2 a Reliable Marker in Differentiating Diffuse Malignant Mesotheliomas of Peritoneum From Serous Carcinomas of Mu¨llerian Origin? Faye F. Gao, MD, PhD, Alyssa M. Krasinskas, MD, and Mamatha Chivukula, MD, FCAP, FASCP peritoneal carcinomatosis or extraovarian carcinoma. In Abstract: Diffuse peritoneal malignant mesotheliomas (DPMM) contrast, serous carcinomas (SC) are an aggressive type of are often disseminated in the peritoneal cavity as multiple cancers that arise from various organs of mullerian lineage nodules including localized masses in the ovaries that are including ovaries, endometrium, fallopian tubes, perito- clinically and histologically similar to serous adenocarcinomas neum, and cervix. Primary peritoneal serous carcinoma of mullerian origin. It is imperative to differentiate these tumors (PPSC) and ovarian serous carcinoma (OSC) are 2 given their diverse responses to chemotherapy and/or radio- histologically similar SC of mullerian origin that have the therapy. PAX2 gene was recently demonstrated in benign propensity to spread to the serosal surface. DPMM may epithelial cells of the female genital tract and in serous also histologically show a carcinomatous growth pattern carcinomas (SC) of mu¨ llerian origin. The aim of our study and is easily confused with PPSC. Although the criteria

Journal

Applied Immunohistochemistry & Molecular MorphologyWolters Kluwer Health

Published: May 1, 2012

There are no references for this article.